Real-World data sought on new HS treatment in russia
NCT ID NCT06517732
First seen Dec 16, 2025 · Last updated May 18, 2026 · Updated 21 times
Summary
This study tracks 107 adults with moderate to severe hidradenitis suppurativa (HS) who are taking secukinumab as part of their normal care. Researchers want to see how well the drug reduces skin abscesses and tunnels in everyday practice. The goal is to understand real-world effectiveness, not to test a new cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Izhevsk, 426039, Russia
-
Novartis Investigative Site
Kaliningrad, 236016, Russia
-
Novartis Investigative Site
Kaliningrad, 236029, Russia
-
Novartis Investigative Site
Kazan', 420012, Russia
-
Novartis Investigative Site
Kemerovo, 650025, Russia
-
Novartis Investigative Site
Krasnodar, 350020, Russia
-
Novartis Investigative Site
Moscow, 107076, Russia
-
Novartis Investigative Site
Moscow, 119881, Russia
-
Novartis Investigative Site
Moscow, 123182, Russia
-
Novartis Investigative Site
Moscow, 129110, Russia
-
Novartis Investigative Site
Nizhny Novgorod, 603950, Russia
-
Novartis Investigative Site
Penza, 440052, Russia
-
Novartis Investigative Site
Saint Petersburg, 197022, Russia
-
Novartis Investigative Site
Samara, 443079, Russia
-
Novartis Investigative Site
Saratov, 410028, Russia
-
Novartis Investigative Site
Stavropol, 355020, Russia
-
Novartis Investigative Site
Tula, 300053, Russia
-
Novartis Investigative Site
Ufa, 450010, Russia
-
Novartis Investigative Site
Yakutsk, 677000, Russia
Conditions
Explore the condition pages connected to this study.